知镜 Cognispect · 医学文献与研究工作台

Real-World Clinical Outcomes Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin: A SEER-Medicare Analysis.

Lotan Y, Raut M, Zhang S, Lai Y, Chang SS, Dave H, Bhattacharya R, Li H, Gao W, Song Y, Fang H, Li J, Shen P.
Clinical genitourinary cancer · 2026-08-05 · PMID 42744730

文献摘要

Introduction Contemporary data on clinical outcomes following Bacillus Calmette-Guérin (BCG) treatment in high-risk non-muscle-invasive bladder cancer (HR-NMIBC) are needed. This study evaluated recurrence and survival in US patients with HR-NMIBC who received BCG. Methods Using Surveillance, Epidemiology and End Results-Medicare data, we identified patients aged ≥ 65 years with a primary diagnosis of HR-NMIBC who received BCG (initiation date = index date). Post-BCG recurrence was assessed overall and by local NMIBC recurrence, progression to muscle-invasive bladder cancer (MIBC), and distant metastasis (DM). Event-free and overall survival were estimated using Kaplan-Meier analysis. Cystectomy use following recurrence was also evaluated. Results A total of 5490 patients with HR-NMIBC who received BCG were included, of whom 33.6% had high-grade Ta, 55.0% T1 (± Ta), and 11.4% Tis (± Ta/T1) at initial diagnosis. Over a median follow-up of 2.9 years, 2178 (39.7%) patients experienced recurrence, 97.2% occurring within the first 5 years after BCG initiation. Recurrence rates for local NMIBC recurrence, progression to MIBC, and DM increased from 15.9%, 4.1%, and 3.7% at 1 year to 33.6%, 15.9%, and 16.7% at 10 years, respectively. Recurrence was similarly high among patients with Tis (42.1%) and T1 (40.6%) disease. Among patients with recurrence, 312 (14.3%) underwent cystectomy, 83.3% of which within 1 year after recurrence. Conclusions In this population-based study, patients with HR-NMIBC experienced substantial recurrence burden following BCG treatment, with the majority of recurrences occurring within 5 years after BCG initiation. These findings underscore the need for improved strategies to effectively delay or prevent recurrence in HR-NMIBC.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。